Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center and Beckman Research Institute, City of Hope
Duarte, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Cancer and Blood Institute of the Desert
Rancho Mirage, California, United States
- Eisenhower Medical Center
Rancho Mirage, California, United States
- Sidney Kimmel Cancer Center
San Diego, California, United States
- Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
- Office of Glenn Tisman
Whittier, California, United States
- Office of Barry S. Berman
Orlando, Florida, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- St. Barnabas Medical Center
Livingston, New Jersey, United States
- Morristown Memorial Hospital
Morristown, New Jersey, United States
- Albany Regional Cancer Center
Albany, New York, United States
- Center for Medical Oncology
Garden City, New York, United States
- Nyu School of Medicine'S Kaplan Comprehensive Cancer Center
New York, New York, United States
- New York Presbyterian Hospital - Cornell Campus
New York, New York, United States
- St. Luke'S-Roosevelt Hospital
New York, New York, United States
- St. Vincents Comprehensive Cancer Center
New York, New York, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- New York Medical College
Valhalla, New York, United States
- Aksm Clinical Research Corporation
Columbus, Ohio, United States
- Earle A. Chiles Research Institute at Providence Portland Medical Center
Portland, Oregon, United States
- Abington Hematology Oncology Associates, Incorporated
Abington, Pennsylvania, United States
- Bryn Mawr Urology
Bryn Mawr, Pennsylvania, United States
- Office of Guy Bernstein, M.D.
Bryn Mawr, Pennsylvania, United States
- Saint Mary Regional Cancer Center
Langhorne, Pennsylvania, United States
- North Penn Hospital
Lansdale, Pennsylvania, United States
- Hematology/oncology Associates of Ne Pennsylvania, P.C.
Scranton, Pennsylvania, United States
- American Oncology Resources
Dallas, Texas, United States
- Devine Tidewater Urology
Norfolk, Virginia, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Cancer Care Northwest
Spokane, Washington, United States
- Hematology Oncology Northwest, P.C.
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 1999
- Primary completion
- 30 Sept 2004
- Completion
- 30 Sept 2004
- Last update posted
- 1 Nov 2010
- Registered enrollment
- 127
- Registry id
- NCT00005947
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.